REST/NRSF, miRNAs, and tissue remodeling in adenomyosis pathophysiology
REST/NRSF, miRNAs, and tissue remodeling in adenomyosis pathophysiology
批准号:
10277800
负责人:
Vargheese Mani Chennathukuzhi
金额:
$64.27万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-08-09 至 2026-04-30
关键词:
3&apos Untranslated RegionsAdenomyosisBiologicalBiological AssayCell CommunicationCell ProliferationCellsClinicalDataDevelopmentDiagnosisDiseaseDisease ProgressionEndometrialEndometriumEpithelial CellsEventExperimental ModelsFunctional disorderGene ExpressionGlandHormonalHumanHysterectomyImageIn VitroKnowledgeLeadMediatingMediator of activation proteinMenstruationMicroRNAsMyometrialNeuronsNon-MalignantOutcome StudyPainPathogenesisPathologicPathway interactionsPelvic PainPrognostic MarkerRE1-silencing transcription factorRegulationReporterReportingResearchRoleSeriesSignal PathwaySmooth MuscleSpecimenTestingTissuesTranscription RepressorUncertaintyUterine DiseasesUterusWomanWomen&aposs Groupcell motilityconditional knockoutdiagnostic biomarkereffective therapyendometrial stromaexperimental studyin vitro Modelinjury and repairinnovationinsightmigrationmouse modelmyometriumnoveloptimal treatmentsreproductivestemtheoriestissue injurytranscription factor RESTtranscriptome sequencingyoung woman
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Adenomyosis is a nonmalignant uterine disease characterized by endometrial stroma and glands found
within the myometrium. Adenomyosis has been associated with heavy and painful menstrual periods, pelvic
pain, pain with intercourse, and reproductive dysfunction. However, now that imaging is identifying
adenomyosis in younger and more varied women than those electing hysterectomy where pathological
diagnosis occurred, many of our assumptions about the clinical disease are changing. Additionally, the only
widely accepted and effective treatments for adenomyosis, hysterectomy and hormonal suppression, are
unacceptable for this wider group of women. Much of our uncertainty on diagnosis and treatment for
adenomyosis stem from our uncertainty on its' pathogenesis. The most common theory of adenomyosis
development centers on the involvement of tissue injury and repair mechanisms with resulting adenomyosis
development from invagination of the endometrial basalis into the myometrium (the invasion/invagination
theory). While emerging data support a role for this theory and the involvement of cell migration, proliferation
and invasion in adenomyosis development, a detailed understanding on the mediators and mechanisms is
clearly lacking. To fill this critical gap in our knowledge we will perform a series of experiments which integrate
well-defined human specimens, novel mouse models and rigorous in vitro approaches to identify key
components of a REST-miRNA-tissue remodeling cascade and demonstrate the functionality of this pathway in
the pathogenesis of adenomyosis. The specific hypothesis to be tested in this application is that reduced
expression of endometrial and/or myometrial REST induces alterations in a miRNA-mediated tissue
remodeling cascade which augments adenomyosis development. To test this hypothesis, we will delineate
expression of a novel REST-miRNA mediated tissue remodeling pathway in adenomyosis and define REST's
function using novel experimental mouse models. Using in vitro models for cell proliferation, migration and
invasion, we will decipher cell to cell communication between myometrial-endometrial REST-miRNA tissue
remodeling pathway signaling relevant to adenomyosis pathophysiology. Together, these experiments will
provide novel insight into the role of REST in adenomyosis development and in turn, may lead to identification
of novel treatment targets for this disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
REST/NRSF, miRNAs, and tissue remodeling in adenomyosis pathophysiology
-
批准号:10617304
-
项目类别:
-
资助金额:$63.62万
-
财政年份:2021
-
负责人:Vargheese Mani Chennathukuzhi
-
依托单位:
Allosteric CDK2 inhibitor Discovery and Development for Male Contraception
-
批准号:10018520
-
项目类别:
-
资助金额:$37.62万
-
财政年份:2019
-
负责人:Vargheese Mani Chennathukuzhi
-
依托单位:
Small molecule GPR10 antagonists for the treatment of uterine fibroids
-
批准号:9759969
-
项目类别:
-
资助金额:$30.2万
-
财政年份:2018
-
负责人:Vargheese Mani Chennathukuzhi
-
依托单位:
Cell-cycle regulatory kinases as targets for male contraceptive drug development
-
批准号:9253022
-
项目类别:
-
资助金额:$30.25万
-
财政年份:2014
-
负责人:Vargheese Mani Chennathukuzhi
-
依托单位:
The role of REST in the pathogenesis of uterine fibroids
-
批准号:9261556
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2013
-
负责人:Vargheese Mani Chennathukuzhi
-
依托单位:
The role of REST in the pathogenesis of uterine fibroids
-
批准号:9055746
-
项目类别:
-
资助金额:$33.19万
-
财政年份:2013
-
负责人:Vargheese Mani Chennathukuzhi
-
依托单位:
The role of REST in the pathogenesis of uterine fibroids
-
批准号:8720039
-
项目类别:
-
资助金额:$34.31万
-
财政年份:2013
-
负责人:Vargheese Mani Chennathukuzhi
-
依托单位:
The role of REST in the pathogenesis of uterine fibroids
-
批准号:8596606
-
项目类别:
-
资助金额:$36.08万
-
财政年份:2013
-
负责人:Vargheese Mani Chennathukuzhi
-
依托单位:
H2-Gamendazole analogues as reversible non-hormonal male contraceptive agents
-
批准号:9127311
-
项目类别:
-
资助金额:$25.94万
-
财政年份:2012
-
负责人:Vargheese Mani Chennathukuzhi
-
依托单位:
海外基金